Published in Clin Neurol Neurosurg on January 01, 1992
Recognizing syncope: pitfalls and surprises. J R Soc Med (1996) 1.14
Reliability of the diagnosis of a first seizure. Clin Neurol Neurosurg (1993) 0.75
FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet (1993) 4.21
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet (1997) 3.56
Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene (1999) 3.00
The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys (1994) 2.97
Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol (1993) 2.25
Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2001) 2.14
Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet (1990) 2.09
Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med (1994) 2.03
Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology (2010) 2.01
Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet (1999) 1.92
Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science (1990) 1.92
Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology (2004) 1.73
Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet (1996) 1.71
Amyloid beta protein (Abeta) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects. J Neuropathol Exp Neurol (2000) 1.66
Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept. Phys Med Biol (2009) 1.63
Characterization and localization of the Huntington disease gene product. Hum Mol Genet (1993) 1.60
Juvenile Huntington disease. Hum Genet (1986) 1.57
Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol (1998) 1.57
Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity. Hum Mol Genet (2000) 1.56
Eight-channel transmit/receive body MRI coil at 3T. Magn Reson Med (2007) 1.54
FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J Med Genet (2004) 1.50
Cytotoxic leucocyte iso-antibodies formed during the first pregnancy. Vox Sang (1969) 1.45
Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry (2005) 1.45
Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol (2001) 1.42
Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum Mol Genet (1996) 1.42
Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology (2007) 1.41
Tourette's syndrome and right hemisphere dysfunction. Br J Psychiatry (1993) 1.40
Clinimetrics of postural instability in Parkinson's disease. J Neurol (1998) 1.39
[Don't let the patient with Parkinson's disease fall!]. Ned Tijdschr Geneeskd (1998) 1.39
Should all patients with malignant astrocytoma have postoperative radiotherapy? Acta Neurochir (Wien) (1991) 1.39
The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve Suppl (1995) 1.39
Prevalence of subjective dysphagia in community residents aged over 87. BMJ (1990) 1.38
Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease. Mov Disord (1996) 1.38
Impact of Huntington's disease on quality of life. Mov Disord (2001) 1.37
De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet (2000) 1.37
Lack of GTP-insensitive D2 dopamine receptors in Huntington's disease. J Neurol Sci (1989) 1.37
Transient loss of consciousness: the value of the history for distinguishing seizure from syncope. J Neurol (1991) 1.36
Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics (1991) 1.35
Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia (1986) 1.35
Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet (1998) 1.34
Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet (1994) 1.34
Acute myelopathy caused by fibrocartilaginous emboli. Neurology (1981) 1.29
Recommendations for the predictive genetic test in Huntington's disease. Clin Genet (2012) 1.27
Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res (1990) 1.26
Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet (1993) 1.25
Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale. Mov Disord (1994) 1.25
Localization of a gene for Möbius syndrome to chromosome 3q by linkage analysis in a Dutch family. Hum Mol Genet (1996) 1.21
D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology (2003) 1.20
Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. J Med Genet (1993) 1.20
Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions. Genomics (1994) 1.19
Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles. Neurology (2003) 1.18
On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am J Med Genet (1993) 1.18
No protective effect of apolipoprotein E epsilon 2 allele in Dutch hereditary cerebral amyloid angiopathy. Ann Neurol (1995) 1.17
Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum Mol Genet (1995) 1.17
Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry (1993) 1.16
Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res (1997) 1.13
Telemetric EEG and video monitoring in epilepsy. Neurology (1981) 1.13
Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Clinical and computed tomographic analysis of 24 cases. Arch Neurol (1990) 1.09
A new approach in the assessment of motor activity in Parkinson's disease. J Neurol Neurosurg Psychiatry (1991) 1.09
Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol (2001) 1.08
Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. J Clin Invest (1993) 1.07
Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol (1993) 1.07
Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1993) 1.05
Nuclear membrane indentations in Huntington's chorea. J Neurol Sci (1983) 1.05
Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study. J Neurol Neurosurg Psychiatry (1997) 1.05
Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology (2004) 1.04
Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter. Am J Hum Genet (1992) 1.04
A review of the assessment of dyskinesias. Mov Disord (1999) 1.03
Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain (1998) 1.02
Investigation of gait in elderly subjects over 88 years of age. J Geriatr Psychiatry Neurol (1992) 1.02
Somatic pairing between subtelomeric chromosome regions: implications for human genetic disease? Chromosome Res (1999) 1.02
Understanding the low uptake of presymptomatic DNA testing for Huntington's disease. Lancet (1992) 1.01
Hyponatraemia due to amantadine hydrochloride and L-dopa/carbidopa. Lancet (1993) 1.01
Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy. Epilepsia (1984) 1.01
Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol (1997) 1.00
The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease. Neurosci Lett (1991) 1.00
FRG1P is localised in the nucleolus, Cajal bodies, and speckles. J Med Genet (2004) 1.00
Temporal characteristics of seizures and epileptiform discharges. Electroencephalogr Clin Neurophysiol (1984) 1.00
Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J Neurol (2007) 0.99
Long latency postural responses are functionally modified by cognitive set. Electroencephalogr Clin Neurophysiol (1991) 0.99
Unified Huntington's disease rating scale: a follow up. Mov Disord (1998) 0.99
Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol (1998) 0.99
Tiapride in the treatment of Huntington's chorea. Acta Neurol Scand (1982) 0.99
Localisation of the gene for a dominant congenital spinal muscular atrophy predominantly affecting the lower limbs to chromosome 12q23-q24. Eur J Hum Genet (1998) 0.99
Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families. Neurology (2007) 0.98
The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands. Brain (1996) 0.98
Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J Neuropathol Exp Neurol (1990) 0.98
Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. Am J Ment Retard (1997) 0.98
Pathophysiology of chorea and bradykinesia in Huntington's disease. Mov Disord (1999) 0.97
Facioscapulohumeral muscular dystrophy in early childhood. Arch Neurol (1994) 0.96
Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion. Mov Disord (1998) 0.96
Paroxysmal kinesigenic choreoathetosis as presenting symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry (1991) 0.96
Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch Neurol (1994) 0.96
A second gene for autosomal dominant Möbius syndrome is localized to chromosome 10q, in a Dutch family. Am J Hum Genet (1999) 0.96
Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I--A review of clinical, radiologic and genetic aspects. Brain Pathol (1996) 0.96